B. Grosbois

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome

Hervé Avet‐Loiseau, Michel Attal, Philippe Moreau et al. · Blood · 2007 · 905 citations · Full text

Medicine, Genetics, Hematology +15

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial

Thierry Façon, Jean Yves Mary, Cyrille Hulin et al. · The Lancet · 2007 · 870 citations

Medicine, Hematology, Oncology +17

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

Arnaud Jaccard, Philippe Moreau, Véronique Leblond et al. · New England Journal of Medicine · 2007 · 518 citations

Medicine, Hematology, Oncology +14

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation

Hervé Avet‐Loiseau, Thierry Façon, B. Grosbois et al. · Blood · 2002 · 357 citations · Full text

Medicine, Genetics, Oncology +13

Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

Alain Fischer, Johan Provot, Jean‐Philippe Jaïs et al. · Journal of Allergy and Clinical Immunology · 2017 · 317 citations

Life Sciences, Immunology, Internal Medicine +11